Stem Holdings, Inc.
company.status.inactiveCIK 1697834fmd_04ZNJ6CB5DW6FN8PWEHGCRMZK7Manufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Oct 02, 2015 to Sep 30, 2023, 29 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 1 | 2 | 14 | 24 | 19 | – |
| Cost of revenue | – | – | 2 | 10 | 14 | 14 | – |
| Gross profit | – | 1 | 0 | 4 | 7 | 2 | – |
| Realized investment gains (losses) | – | – | – | 0 | 0 | – | – |
| Gain on sale of real estate | – | – | – | – | 1 | 1 | – |
| Total operating expenses | 3 | 10 | 22 | 13 | 20 | 7 | 4 |
| Operating income | (3) | (8) | (22) | (10) | (14) | (7) | (4) |
| Interest expense | – | – | – | – | 2 | 1 | 1 |
| Other non-operating income (expense) | 0 | (0) | (0) | (2) | 3 | 4 | (1) |
| Income before taxes | (3) | (8) | (22) | (11) | (64) | – | – |
| Net income from continuing operations | – | – | – | – | (10) | (3) | (5) |
| Net income | (3) | (9) | (29) | (11) | (64) | (17) | (19) |